首页 | 本学科首页   官方微博 | 高级检索  
     


Neoadjuvant chemotherapy or chemoradiotherapy for adenocarcinoma of the esophagus
Authors:Els Visser MD  David Edholm MD  PhD  B. Mark Smithers MBBS  FRACS   FRCSEng  FRCSEd  Iain G. Thomson MBBS  FRACS  Bryan H. Burmeister  Euan T. Walpole  David C. Gotley FRACS  MD   PhD  Warren L. Joubert  Victoria Atkinson  Tao Mai  Janine M. Thomas BsHSc  Andrew P. Barbour MBBS  PhD   FRACS  FACS
Affiliation:1. Upper Gastrointestinal/Soft Tissue Unit, Discipline of Surgery, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia;2. Institution of Surgical Sciences, Uppsala University, Sweden;3. The University of Queensland, Brisbane, Queensland, Australia;4. Mater Medical Research Institute, Mater Health Services, Raymond Terrace, South Brisbane, Australia;5. Medical Oncology, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia;6. Radiation Oncology, Division of Cancer Services, Princess Alexandra Hospital, Woolloongabba, Queensland, Australia;7. The University of Queensland, Diamantina Institute, Translational Research Institute, Woolloongabba, Queensland, Australia
Abstract:
Keywords:adenocarcinoma  esophageal carcinoma  neoadjuvant therapy  outcome  survival
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号